---
figid: PMC7139574__cancers-12-00642-g001
figlink: pmc/articles/PMC7139574/figure/cancers-12-00642-f001/
number: F1
caption: Biological pathways involved in chronic lymphocytic leukemia (CLL) pathogenesis
  and harboring therapeutic implications. (i) Venetoclax (in red) binds and inhibits
  the BCL2 anti-apoptotic protein, which is frequently impaired by a variety of molecular
  mechanisms (e.g., del13q14), thus restoring the apoptosis in CLL cells. (ii) Bruton’s
  tyrosine kinase (BTK), a pivotal kinase located downstream to the BCR pathway, can
  be targeted by BTK inhibitors such as ibrutinib (in red). (iii) The activation of
  the non-canonical NF-κB pathway contributes to cell survival and progression. (iv)
  Notch homolog 1 (NOTCH1) mutations disrupt the PEST domain (in orange) of the NOTCH
  intracellular domain (NICD), leading to constitutive transcription of target genes
  promoting survival and proliferation. (v) The nuclear TP53 and Ataxia telangiectasia
  mutated (ATM) proteins are involved in the DNA damage response pathway.
pmcid: PMC7139574
papertitle: Precision Medicine Management of Chronic Lymphocytic Leukemia.
reftext: Riccardo Moia, et al. Cancers (Basel). 2020 Mar;12(3):642.
pmc_ranked_result_index: '74985'
pathway_score: 0.9704183
filename: cancers-12-00642-g001.jpg
figtitle: Biological pathways involved in chronic lymphocytic leukemia (CLL) pathogenesis
  and harboring therapeutic implications
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7139574__cancers-12-00642-g001.html
  '@type': Dataset
  description: Biological pathways involved in chronic lymphocytic leukemia (CLL)
    pathogenesis and harboring therapeutic implications. (i) Venetoclax (in red) binds
    and inhibits the BCL2 anti-apoptotic protein, which is frequently impaired by
    a variety of molecular mechanisms (e.g., del13q14), thus restoring the apoptosis
    in CLL cells. (ii) Bruton’s tyrosine kinase (BTK), a pivotal kinase located downstream
    to the BCR pathway, can be targeted by BTK inhibitors such as ibrutinib (in red).
    (iii) The activation of the non-canonical NF-κB pathway contributes to cell survival
    and progression. (iv) Notch homolog 1 (NOTCH1) mutations disrupt the PEST domain
    (in orange) of the NOTCH intracellular domain (NICD), leading to constitutive
    transcription of target genes promoting survival and proliferation. (v) The nuclear
    TP53 and Ataxia telangiectasia mutated (ATM) proteins are involved in the DNA
    damage response pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - BCR
  - CD40
  - TNFRSF13C
  - TNFRSF11A
  - LTBR
  - TRAF3
  - TRAF2
  - BIRC3
  - MAP3K14
  - NOTCH1
  - BTK
  - CHUK
  - FBXW7
  - PLCG2
  - MAPK3
  - MAPK1
  - ATM
  - MAPK14
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK9
  - MAPK10
  - MAK
  - ibrutinib
  - tumor
genes:
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: CD40
  symbol: CD40
  source: hgnc_symbol
  hgnc_symbol: CD40
  entrez: '958'
- word: BAFFR
  symbol: BAFFR
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF13C
  entrez: '115650'
- word: RANK
  symbol: RANK
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF11A
  entrez: '8792'
- word: LTBR
  symbol: LTBR
  source: hgnc_symbol
  hgnc_symbol: LTBR
  entrez: '4055'
- word: TRAF3
  symbol: TRAF3
  source: hgnc_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: BIRC3
  symbol: BIRC3
  source: hgnc_symbol
  hgnc_symbol: BIRC3
  entrez: '330'
- word: МАРЗК14
  symbol: MAP3K14
  source: hgnc_symbol
  hgnc_symbol: MAP3K14
  entrez: '9020'
- word: NOTCH1
  symbol: NOTCH1
  source: hgnc_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: BTK
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: IKKA
  symbol: IKKA
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: FBXW7
  symbol: FBXW7
  source: hgnc_symbol
  hgnc_symbol: FBXW7
  entrez: '55294'
- word: RelB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: RelB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: PLCY2
  symbol: PLCG2
  source: hgnc_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ATM
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
chemicals:
- word: ibrutinib
  source: MESH
  identifier: C551803
diseases:
- word: tumor
  source: MESH
  identifier: D009369
figid_alias: PMC7139574__F1
redirect_from: /figures/PMC7139574__F1
figtype: Figure
---
